iSpecimen CEO Katharyn Field departs; Shahin Behroyan appointed CEO effective Aug 26, 2026

iSpecimen Inc.

Katharyn Field transitions from CEO role on Aug 26, 2026; no disagreement with Board.
Board appoints Shahin Behroyan as CEO, effective immediately, via independent contractor agreement.
Contract pays $350,000/year in $29,166.67 monthly installments; $67,500 severance if terminated without cause.
Behroyan is Vancouver-based entrepreneur; will remain independent contractor, no employee benefits.
Agreement filed as Exhibit 10.1; Behroyan will advise and oversee initiatives.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Shahin Behroyan

Chief Executive Officer

ISPC · iSpecimen Inc.

Effective: 2026-08-26
Filed: August 31, 2026, 5:22 PM ET

On August 26, 2026, the Board appointed Shahin Behroyan as Chief Executive Officer of the Company, effective immediately.

Departed

Katharyn Field

Chief Executive Officer

ISPC · iSpecimen Inc.

Effective: 2026-08-26
Successor: Shahin Behroyan
Filed: August 31, 2026, 5:22 PM ET

On August 26, 2026, Katharyn Field informed the Board of Directors (the “Board”) of iSpecimen Inc. (the “Company”) of her decision to transition from her role as Chief Executive Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Shahin Behroyan was appointed as Chief Executive Officer at iSpecimen Inc..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On August 26, 2026, the Board appointed Shahin Behroyan as Chief Executive Officer of the Company, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Katharyn Field changed role as Chief Executive Officer at iSpecimen Inc..

Action: transitioned
Role: Chief Executive Officer

Exact text from the filing

On August 26, 2026, Katharyn Field informed the Board of Directors (the “Board”) of iSpecimen Inc. (the “Company”) of her decision to transition from her role as Chief Executive Officer.

View on SEC.gov

iSpecimen Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-095801

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.